ReviewOncoimmunology2022
Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy.
Adriana Petrazzuolo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it
ReviewOncoimmunology2022
Adriana Petrazzuolo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.